Biotecnología
Biotecnología
Polyplus Introduces LipidBrick for LNP Formulation in mRNA Therapeutics
18/03/2023 -
LipidBrick IM21.7c broadens the scope of LNP usage in various applications from prophylactic vaccines to therapeutic and oncology applications.
Culture Biosciences Shifts Focus, Appoints New Leadership Team
15/03/2023 -
To focus on upstream bioprocess development of new therapeutics with leadership team enhancing expertise in the biotech and biopharma industries.
Sumitovant Biopharma Acquires Myovant Sciences in $1.7B Deal
14/03/2023 -
Will combine expertise, platforms and resources to address unmet needs in women's health and prostate cancer.
Vitrian, The Howard Hughes Corp. Partner to Develop Life Science Projects
14/03/2023 -
The venture aims to meet the needs of companies focused on in-house manufacturing (from biopharma to industrial biology) as well as CDMOs.
Cytovance, Phenotypeca Partner to Enhance Strain Development for Microbial Biomanufacturing
14/03/2023 -
Alliance aims to accelerate the development of high-performance yeast strains and to improve the efficiency of biologics production.
Janssen Licenses Biocytogen's RenLite Platform
10/03/2023 -
Antibodies assembled after RenLite discovery have a traditional antibody structure with properties that are advantageous for downstream CMC development.
Akston Biosciences Ends Vaccine Partnership with Stelis
10/03/2023 -
Akston has reclaimed all commercial rights to AKS-452, its room temperature stable COVID-19 vaccine.
IAVI, BARDA Expand Partnership to Advance Filovirus Vaccine Candidates
07/03/2023 -
The funding from BARDA will enable IAVI to continue critical development and testing of filovirus vaccine candidates to facilitate better preparedness.
WestVac Biopharma Acquires Accreditation as Foreign Drug Manufacturer in Japan
07/03/2023 -
The accreditation is a significant step toward the commercialization of its COVID-19 vaccine in Japan.
Biotecnología en el Microcentro: las oficinas vacías que se transforman en laboratorios de última generación
03/03/2023 -
Hay varias iniciativas del rubro biotecnológico en esta migración espontánea al lugar menos esperado: el Microcentro porteño. Ciencias de la vida para reverdecer un...
KINRIX
02/03/2023 -
Changes to your package insert to the Dosage and Administration section regarding visual inspection by the user for cracked vials or syringes prior to administration of the vaccine and non-use of...
NIIMBL Unveils 3 New Vaccine Manufacturing Projects
02/03/2023 -
Announces $1.7 million from the Global Health Fund.
Bavarian Nordic Acquires Travel Vaccines from Emergent Biosolutions
02/03/2023 -
The acquisition adds two revenue-generating vaccines for the prevention of cholera and typhoid fever.
Aji Bio-Pharma Develops Highly Functional Ancestral RNA Ligase
02/03/2023 -
New enzyme for double strand oligonucleotide formation with high productivity.
GenScript ProBio, RVAC Medicines Enter GMP Plasmid DNA Manufacturing Pact
02/03/2023 -
Alliance will enable GenScript ProBio to accelerate its clinical manufacturing of mRNA-based COVID-19 vaccine, RVM-V001.
Influenza A (H1N1) 2009 Monovalent Vaccines Descriptions and Ingredients
02/03/2023 -
The Description and Ingredients information on this page is excerpted from the package inserts for each of the licensed Influenza A (H1N1) 2009 Monovalent Vaccines
Report Reveals Cell & Gene Therapy CDMO Market to Reach $18.6B by 2032
02/03/2023 -
New partnerships with pharma, biopharma companies have enabled CDMOs to fuel the rapid growth of capabilities and capacities.
Keymed, Lepu Biopharma Enter Global License Agreement with AstraZeneca for CMG901
02/03/2023 -
AstraZeneca will be responsible for the research, development, manufacture and commercialization of CMG901 globally.
Menactra
02/03/2023 -
Product approval information for the Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine also known as Menactra
Multilingual COVID-19 Vaccines Myths Social Media Toolkit
16/02/2023 -
COVID-19 Vaccines Myths social media toolkit in English, Spanish, Chinese, Korean, Vietnamese and Tagalog.
TVM Capital Life Science Creates New Biotechnology Company
15/02/2023 -
Plans to develop a first-in-class mAb to clinical proof-of-concept in hay fever.
